Elite Pharmaceuticals Inc (ELTP)

[Hike]

MT:
Is this what you are referring to?

"Sometime end of March or April, we will start another BE pivotal study for the once-a-day."

The "once a day" Oxy was ELI-154 (non-ART) or ELI-216. These don't show on the pipeline page. Not sure if they were renamed or what.
I sent a note to Diane asking for clarification.

ELI-201 is the twice daily abuse deterrent oxycodone/naltrexone product so we know that wasn't it. Pivotal trials started in July for this: http://www.elitepharma.com/investor_relations.asp?goto=388

ELI-200 is Elite’s undisclosed abuse deterrent opioid product. Some speculate it could be "a better Embeda" or it could be ELI-216 renamed. But hey, it's undisclosed so it could be anything. It could very well be what they referred to above. Pivotal study for this was announced as completed on 3/5/2014. See: http://www.elitepharma.com/investor_relations.asp?goto=378

ELI-202 is also an undisclosed Abuse resistant opiod product. So that could be it. Pivotal trial commenced in May. Press release here:
http://globenewswire.com/news-release/2014/05/19/637479/10082202/en/Elite-Pharmaceuticals-Initiates-Pivotal-Bioequivalence-Study-for-Third-Opioid-Abuse-Deterrent-Product.html